# Innate Immunity Trained in the Protective Response of Vaccine Candidates Against Intracellular Pathogens

**Authors:** Jefferson B. S. Oliveira, Laice A. Silva, Monique F. S. Sousa, Aldcejam M. F. Junior, Camila G. Almeida, Robson S. Barducci, Marcella P. Milazzotto, Humberto M. Brandão, Renato L. Santos, Tatiane A. Paixão

PMC · DOI: 10.3390/vaccines14020197 · Vaccines · 2026-02-23

## TL;DR

This study shows that trained innate immunity can boost the effectiveness of inactivated vaccines against certain bacterial infections but may reduce the effectiveness of live vaccines.

## Contribution

The study reveals that β-glucan enhances inactivated vaccine efficacy against Brucella ovis and Listeria monocytogenes but impairs live attenuated vaccine performance.

## Key findings

- β-glucan reduced bacterial colonization in mice vaccinated with gamma-irradiated Brucella ovis.
- 50% of trained and vaccinated mice showed no detectable Listeria monocytogenes after challenge.
- Overstimulation with β-glucan doses impaired infection control, suggesting a negative effect on trained immunity.

## Abstract

Background/Objectives: Trained innate immunity refers to the enhanced responsiveness of innate immune cells, particularly macrophages, following exposure to stimuli such as β-glucan or zymosan, enabling improved defense against unrelated pathogens. This phenomenon has been widely investigated to better understand host–pathogen interactions and to support the development of improved infection control strategies. This study evaluated whether these training stimuli could enhance the protective efficacy of attenuated or inactivated vaccine models against Brucella ovis and Listeria monocytogenes infection. Methods: Trained innate immunity was induced in vivo using β-glucan or zymosan, and seven days later mice were vaccinated with attenuated or gamma-irradiated formulations and subsequently challenged with B. ovis or L. monocytogenes. Vaccine-induced protection and immune responses were assessed through multiple experimental approaches. Results: β-glucan significantly reduced bacterial infection in vitro in bone-marrow-derived macrophages and in vivo in target organs compared with zymosan. Although β-glucan did not enhance the efficacy of the attenuated B. ovis ΔabcBA vaccine, it markedly reduced bacterial colonization in mice vaccinated with gamma-irradiated B. ovis. β-glucan also did not improve the efficacy of the gamma-irradiated L. monocytogenes vaccine; however, 50% of the trained and vaccinated mice showed no detectable bacterial recovery. Increasing the number of β-glucan doses negatively affected infection control, suggesting that overstimulation may impair trained immunity. Conclusion: Trained innate immunity enhances the protective effect of inactivated experimental vaccines against B. ovis and L. monocytogenes, while exerting a detrimental influence on the efficacy of a live attenuated B. ovis vaccine model.

## Linked entities

- **Species:** Brucella ovis (taxon 236), Listeria monocytogenes (taxon 1639), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, H2 (histocompatibility-2, MHC) [NCBI Gene 111364] {aka H-2, MHC-II}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, Bgn (biglycan) [NCBI Gene 12111] {aka BG, DSPG1, PG-S1, PGI, SLRR1A}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Cd80 (CD80 antigen) [NCBI Gene 12519] {aka B71, Cd28l, Ly-53, Ly53, MIC17, TSA1}
- **Diseases:** orchitis (MESH:D009920), encephalitis (MESH:D004660), Infection (MESH:D007239), abortion (MESH:D000026), placentitis (MESH:D010922), epididymitis (MESH:D004823), inflammation (MESH:D007249), liver lesions (MESH:D008107), injury to (MESH:D014947), overdose (MESH:D062787), infectious (MESH:D003141), septicemia (MESH:D018805), brucellosis (MESH:D002006), Listeria infection (MESH:D008088), necrosis (MESH:D009336), tuberculosis (MESH:D014376), bacterial (MESH:D001424), stillbirth (MESH:D050497)
- **Chemicals:** TritonX-100 (MESH:D017830), agar (MESH:D000362), acetone (MESH:D000096), glucans (MESH:D005936), streptomycin (MESH:D013307), Estradiol (MESH:D004958), MOPS (MESH:C008550), AC (MESH:D000186), polysaccharides (MESH:D011134), xylene (MESH:D014992), MTT (MESH:C070243), xylazine hydrochloride (MESH:D014991), Chitosan (MESH:D048271), Hematoxylin (MESH:D006416), Alginate (MESH:D000464), penicillin (MESH:D010406), glycerol (MESH:D005990), paraffin (MESH:D010232), 3-(4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H-tetrazolium bromide (MESH:C000598529), Brain Heart Infusion broth medium (-), NaCl (MESH:D012965), Trypan blue (MESH:D014343), kanamycin (MESH:D007612), formalin (MESH:D005557), reactive oxygen species (MESH:D017382), Zymosan (MESH:D015054), beta-Glucan (MESH:D047071), PBS (MESH:D007854), Eosin (MESH:D004801), PVP (MESH:D011205), sodium acetate (MESH:D019346), TSA (MESH:C481298), SDS (MESH:D012967), acetic acid (MESH:D019342), alcohol (MESH:D000438), gentamicin (MESH:D005839), paraformaldehyde (MESH:C003043), LPS (MESH:D008070), lactosylceramide (MESH:C009744), water (MESH:D014867), ketamine hydrochloride (MESH:D007649), CO2 (MESH:D002245)
- **Species:** Listeria (genus) [taxon 1637], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Listeria monocytogenes (species) [taxon 1639], Bacillus sp. CG (species) [taxon 1196795], Escherichia coli (E. coli, species) [taxon 562], Brucella ovis (species) [taxon 236], Candida albicans (species) [taxon 5476], Bos taurus (bovine, species) [taxon 9913], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Brucella (genus) [taxon 234]
- **Cell lines:** BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), L929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_AR58), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945005/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945005/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945005/full.md

---
Source: https://tomesphere.com/paper/PMC12945005